Updated Jul 16, 2026
Mansbach Harry H is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Harry H. Mansbach is the Chief Medical Officer at 89bio, Inc., where he has been involved in the company's medical and clinical strategy. He has filed multiple SEC documents related to his role but is not widely recognized outside of the company.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-31 | ETNB | 89bio, Inc. | J — Other acquisition / disposition | 352.7K | — | |
| 2025-10-31 | ETNB | 89bio, Inc. | A — Grant or award | 50.0K | $0.00 | |
| 2025-08-01 | ETNB | 89bio, Inc. | F — Tax withholding / forfeiture | 7.7K | $9.16 | $70K |
| 2025-06-12 | ETNB | 89bio, Inc. | F — Tax withholding / forfeiture | 8.5K | $9.62 | $82K |
| 2024-12-16 | ETNB | 89bio, Inc. | A — Grant or award | 95.0K | $0.00 |
Harry H. Mansbach is the Chief Medical Officer at 89bio, Inc., where he has been involved in the company's medical and clinical strategy. He has filed multiple SEC documents related to his role but is not widely recognized outside of the company.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mansbach Harry H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.